150 related articles for article (PubMed ID: 12657873)
21. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
22. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
Caldwell SH; Chang C; Macik BG
Hepatology; 2004 Mar; 39(3):592-8. PubMed ID: 14999675
[TBL] [Abstract][Full Text] [Related]
23. An approach to transfusion and hemorrhage in trauma: current perspectives on restrictive transfusion strategies.
Tien H; Nascimento B; Callum J; Rizoli S
Can J Surg; 2007 Jun; 50(3):202-9. PubMed ID: 17568492
[TBL] [Abstract][Full Text] [Related]
24. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.
Gowers CJ; Parr MJ
Anaesth Intensive Care; 2005 Apr; 33(2):196-200. PubMed ID: 15960401
[TBL] [Abstract][Full Text] [Related]
25. Recombinant activated factor VII for non-hemophiliac bleeding patients.
Uhlmann EJ; Eby CS
Curr Opin Hematol; 2004 May; 11(3):198-204. PubMed ID: 15257021
[TBL] [Abstract][Full Text] [Related]
26. Potential uses of recombinant human factor VIIa in veterinary medicine.
Kristensen AT; Edwards ML; Devey J
Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1437-51. PubMed ID: 14664207
[TBL] [Abstract][Full Text] [Related]
27. Ongoing NovoSeven trials.
Erhardtsen E
Intensive Care Med; 2002 Oct; 28 Suppl 2():S248-55. PubMed ID: 12404094
[TBL] [Abstract][Full Text] [Related]
28. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review.
Mathew P
Thromb Haemost; 2004 Oct; 92(4):738-46. PubMed ID: 15467904
[TBL] [Abstract][Full Text] [Related]
29. Transfusion of blood products in trauma: an update.
Fraga GP; Bansal V; Coimbra R
J Emerg Med; 2010 Aug; 39(2):253-60. PubMed ID: 19345046
[TBL] [Abstract][Full Text] [Related]
30. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study.
Roitberg B; Emechebe-Kennedy O; Amin-Hanjani S; Mucksavage J; Tesoro E
Neurosurgery; 2005 Nov; 57(5):832-6; discussion 832-6. PubMed ID: 16284552
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.
Carr ME; Martin EJ; Kuhn JG; Ambrose H; Fern S; Bryant PC
Clin Lab; 2004; 50(9-10):529-38. PubMed ID: 15481628
[TBL] [Abstract][Full Text] [Related]
32. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
Weiskopf RB
Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
[TBL] [Abstract][Full Text] [Related]
33. The potential use of recombinant activated factor VII in trauma and surgery.
Sapsford W
Scand J Surg; 2004; 93(1):17-23. PubMed ID: 15116814
[TBL] [Abstract][Full Text] [Related]
34. [Laboratory monitoring of recombinant factor VIIA effects].
Barkagan ZS; Mamaev AN; Tsyvkina LP; Mamaeva IV
Klin Lab Diagn; 2007 May; (5):23-5. PubMed ID: 17665615
[TBL] [Abstract][Full Text] [Related]
35. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
36. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
37. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
Zver S; Andoljsek D; Cernelc P
Eur J Haematol; 2004 Jun; 72(6):455-6. PubMed ID: 15128428
[No Abstract] [Full Text] [Related]
38. Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII.
Flynn JD; Camp PC; Jahania MS; Ramaiah C; Akers WS
ASAIO J; 2004; 50(5):519-21. PubMed ID: 15497395
[TBL] [Abstract][Full Text] [Related]
39. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Franchini M; Manzato F; Salvagno GL; Lippi G
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943
[TBL] [Abstract][Full Text] [Related]
40. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
Lang E
Ann Intern Med; 2014 Apr; 160(8):JC6. PubMed ID: 24733223
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
